We are live on ! Find out more
EPZM

Epizyme, Inc
EPZM

Delisted

EPZM was delisted on the 11th of August, 2022.

Back to rankings

137 hedge funds and large institutions have $1.04B invested in Epizyme, Inc in 2020 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 48 increasing their positions, 43 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,230% more call options, than puts

Call options by funds: $28.9M | Put options by funds: $2.17M

12% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 43

0% more funds holding in top 10

Funds holding in top 10: 7 → 7 (0)

5% less capital invested

Capital invested by funds: $1.1B → $1.04B (-$53.7M)

9% less funds holding

Funds holding: 151 → 137 (-14)

44% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 32

Holders
137
Holders Change
-14
Holders Change %
-9.27%
% of All Funds
2.42%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.12%
New
18
Increased
48
Reduced
43
Closed
32
Calls
$28.9M
Puts
$2.17M
Net Calls
+$26.8M
Net Calls Change
-$1.54M

Top Buyers

Rank Fund Capital Flow
1
RG
Redmile Group
California
+$14M
2
FM
Frazier Management
Washington
+$9.02M
3
Citadel Advisors
Citadel Advisors
Florida
+$7.41M
4
GIM
Granahan Investment Management
Massachusetts
+$5.58M
5
Morgan Stanley
Morgan Stanley
New York
+$5.18M

Top Sellers

Rank Fund Capital Flow
1
AG
Artal Group
Luxembourg
-$11.9M
2
PC
Pier Capital
Connecticut
-$6.85M
3
MB
MPM BioImpact
Massachusetts
-$6.45M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$4.3M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
-$3.97M
Name Holding Trade Value Shares
Change 		Change in
Stake
FM
26
Frazier Management
Washington
$7.94M +$9.02M +731,436 New
Goldman Sachs
27
Goldman Sachs
New York
$6.8M +$936K +75,847 +14%
Charles Schwab
28
Charles Schwab
California
$6.6M +$43.4K +3,518 +0.6%
N
29
Nuveen
North Carolina
$3.97M -$490K -39,745 -10%
Bank of New York Mellon
30
Bank of New York Mellon
New York
$3.81M +$5.38K +436 +0.1%
Deutsche Bank
31
Deutsche Bank
Germany
$3.24M -$501K -40,620 -12%
FCMI
32
Foresite Capital Management I
California
$3.19M +$617K +50,000 +21%
JP Morgan Chase
33
JP Morgan Chase
New York
$2.9M -$167K -13,563 -5%
RPAM
34
Rhenman & Partners Asset Management
Sweden
$2.88M – – –
Allianz Asset Management
35
Allianz Asset Management
Germany
$2.83M -$424K -34,404 -12%
Macquarie Group
36
Macquarie Group
Australia
$2.25M – – –
CS
37
Credit Suisse
Switzerland
$2.18M +$347K +28,159 +16%
Voloridge Investment Management
38
Voloridge Investment Management
Florida
$2M +$2.27M +183,932 New
California Public Employees Retirement System
39
California Public Employees Retirement System
California
$1.97M -$255K -20,639 -10%
PP
40
PDT Partners
New York
$1.91M +$368K +29,795 +20%
Millennium Management
41
Millennium Management
New York
$1.79M -$3.66M -296,292 -64%
Swiss National Bank
42
Swiss National Bank
Switzerland
$1.74M – – –
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$1.66M +$17.6K +1,426 +0.9%
WJWM
44
Williams Jones Wealth Management
New York
$1.53M +$175K +14,164 +11%
NSIM
45
North Star Investment Management
Illinois
$1.52M +$264K +21,400 +18%
AllianceBernstein
46
AllianceBernstein
Tennessee
$1.49M – – –
Barclays
47
Barclays
United Kingdom
$1.47M -$131K -10,613 -7%
California State Teachers Retirement System (CalSTRS)
48
California State Teachers Retirement System (CalSTRS)
California
$1.47M -$990K -80,233 -37%
ACM
49
Altium Capital Management
New York
$1.41M +$1.6M +130,000 New
State of Wisconsin Investment Board
50
State of Wisconsin Investment Board
Wisconsin
$1.38M -$195K -15,800 -11%
1
2
3 4 5

EPZM Hedge Fund Activity: Q4 2020 in Review

137 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Epizyme, Inc (EPZM) for Q4 2020, worth a combined $1.04B — down 4.9% from $1.1B a quarter earlier.

Sellers outnumbered buyers: 32 funds closed out of EPZM and 18 opened new positions — a net loss of 14 holders — while 43 trimmed existing stakes and 48 added.

The largest buyer was Redmile Group, adding an estimated $14M. The largest seller was Artal Group, exiting entirely with an estimated $11.9M sold.

  • 137 institutional investors held Epizyme, Inc (EPZM) as of Q4 2020, down from 151 in Q3 2020.
  • Funds reported $1.04B of Epizyme, Inc stock for Q4 2020, down 4.9% quarter-over-quarter.
  • 18 funds opened new Epizyme, Inc positions in Q4 2020 and 32 closed out, a net change of -14 holders.
  • The largest Epizyme, Inc buyer in Q4 2020 was Redmile Group, an estimated $14M added.
  • The largest Epizyme, Inc seller in Q4 2020 was Artal Group, an estimated $11.9M sold.

Based on aggregated 13F filings for Q4 2020.